February 2026
The antihypertensive drugs market size is valued at USD 25.50 billion in 2025 and is expected to be worth around USD 37.29 billion by 2035 with a CAGR of 3.87%.
January 2026
The global infertility drugs market size surpassed USD 4.18 billion in 2025 and is projected to hit around USD 7.50 billion by 2035, growing at a CAGR of 6.02%.
January 2026
The global asthma and COPD drugs market size was estimated at USD 43.49 billion in 2025 and is expected to hit USD 92.39 billion by 2035, with a CAGR of 7.83%.
January 2026
The global generic drugs market size is calculated at USD 468.08 billion in 2025 and is predicted to increase from USD 491.67 billion in 2026 to approximately USD 762.48 billion by 2035, expanding at a CAGR of 5% from 2026 to 2035.
January 2026
The global atopic dermatitis drug market size is calculated at USD 15.92 billion in 2025 and is predicted to increase from USD 17.21 billion in 2026 to approximately USD 33.42 billion by 2035, expanding at a CAGR of 7.70% from 2026 to 2035.
January 2026
The global veterinary dermatology drugs market size is calculated at USD 8.96 billion in 2025 and is projected to hit around USD 20.62 billion by 2035 with a CAGR of 8.69%.
January 2026
The global pediatric drugs market size is calculated at USD 163.28 billion in 2025 and is predicted to increase from USD 183.20 billion in 2026 to approximately USD 506.52 billion by 2035, expanding at a CAGR of 11.99% from 2026 to 2035.
December 2025
The global cancer supportive care drugs market size is projected to hit around USD 27.45 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 2.09%.
December 2025
The global nephrology drugs market size is accounted at USD 18.68 billion in 2025 and predicted to increase from USD 19.71 billion in 2026 to approximately USD 31.83 billion by 2035, representing a CAGR of 5.47% from 2026 to 2035.
December 2025
The global uterine fibroid drugs market size is evaluated at USD 3.16 billion in 2025 and is predicted to hit around USD 11.93 billion by 2035, growing at a CAGR of 14.21%.
December 2025
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
December 2025
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 49.39 billion by 2034, growing at a CAGR of 7.61%.
November 2025
The global atherosclerosis drugs market size is projected to hit around USD 24.25 billion by 2034, increasing from USD 17.60 billion in 2025, with a CAGR of 3.63%.
November 2025
The global duchenne muscular dystrophy drugs market size is projected to hit around USD 19.46 billion by 2034, increasing from USD 4.79 billion in 2025, with a CAGR of 16.85%.
November 2025
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 80.81 billion by 2034, growing at a CAGR of 19.53%.
November 2025
The U.S. pain management drugs market size is calculated at USD 32.79 billion in 2025 and is predicted to increase from USD 33.84 billion in 2026 to approximately USD 44.90 billion by 2034, expanding at a CAGR of 3.60% from 2025 to 2034.
November 2025
November 2025
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 17.15 billion by 2034 increasing from USD 8.44 billion in 2025, with a CAGR of 8.18%.
November 2025
The global hyperlipidemia drugs market size is calculated at USD 23.85 billion in 2025 and is projected to surpass USD 33.94 billion by 2034 with a CAGR of 4%.
November 2025
The global DNA repair drugs market size reached USD 9.36 billion in 2025 and is predicted to surpass around USD 30.28 billion by 2034 with a notable CAGR of 13.98%.
November 2025
The U.S. over the counter (OTC) drugs market size is estimated at USD 24.81 billion in 2025 and is predicted to increase from USD 26.00 billion in 2026 to approximately USD 44.17 billion by 2034, expanding at a CAGR of 6.60% from 2025 to 2034.
November 2025
The global cardiovascular drugs market size is calculated at USD 155.96 billion in 2025 and is predicted to increase from USD 162.02 billion in 2026 to approximately USD 214.72 billion by 2034, expanding at a CAGR of 3.62% from 2025 to 2034.
October 2025
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
October 2025
The global contraceptive drugs market size is valued at USD 19.00 billion in 2025 and is expected to hit around USD 31.60 billion by 2034, at a CAGR of 5.82%.
October 2025
The global over the counter (OTC) drugs market size was valued at USD 135.25 billion in 2025 and is expected to hit around USD 242.94 billion by 2034, growing at a CAGR of 6.72%.
October 2025
The global critical care drugs market size was evaluated at USD 1.22 billion in 2025 and is projected to surge around USD 1.91 billion by 2034, with a CAGR of 5.11%.
October 2025
The global pain management drugs market size was calculated at USD 87.19 billion in 2025 and is predicted to increase from USD 90.50 billion in 2026 to approximately USD 125.68 billion by 2034, expanding at a CAGR of 4.10% from 2025 to 2034.
October 2025
The global antifungal drugs market size was exhibited at USD 18.00 billion in 2025 and is projected to hit around USD 24.51 billion by 2034 with a CAGR of 3.49%.
August 2025
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
August 2025
The global pulmonary alveolar proteinosis (PAP) drugs market size was evaluated at USD 750.05 million in 2024 and is predicted to hit around USD 1,478.22 million by 2034, growing at a CAGR of 7.02%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com